We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Freehand three-dimensional echocardiographic evaluation of the effect of telmisartan compared with hydrochlorothiazide on left ventricular mass in hypertensive patients with mild-to-moderate hypertension: a multicentre study.
- Authors
Galzerano, D.; Tammaro, P.; Cerciello, A.; Breglio, R.; Mallardo, M.; Lama, D.; Tuccillo, B.; Capogrosso, P.
- Abstract
Antihypertensive efficacy, effects on left ventricular mass index (LVMI) and tolerability of telmisartan, an angiotensin II receptor blocker, were compared with those of hydrochlorothiazide (HCTZ). Adult patients with mild-to-moderate hypertension and an optimal acoustic window by two-dimensional echocardiography were randomised at baseline to 12 months' double-blind, once-daily treatment with telmisartan 80?mg or HCTZ 25?mg. Two-dimensional echocardiography and freehand precordial three-dimensional echocardiography and 24-h ambulatory blood pressure monitoring were performed at baseline and after treatment. Of the 41 telmisartan group patients and 28 HCTZ group patients, 40 and 25, respectively, completed the study. Following treatment, 24-h mean SBP (telmisartan 157 ± 11 vs 133 ± 7?mmHg, P<0.001; HCTZ 154 ± 10 vs 144 ± 11?mmHg, P<0.003) and DBP (telmisartan 96 ± 6 vs 83 ± 5?mmHg, P<0.001; HCTZ 95 ± 7 vs 87 ± 8?mmHg, P<0.003) were significantly reduced. Telmisartan produced significantly greater 24-h mean SBP and DBP reductions than HCTZ (P<0.001). LVMI was significantly reduced by telmisartan (141 ± 16 vs 125 ± 19?g/m2, P<0.001), but not by HCTZ (139 ± 20 vs 135 ± 22?g/m2). Incidences of adverse events in both the treatment groups were low; two cases of hypokalaemia occurred with HCTZ. In conclusion, telmisartan 80?mg was well tolerated and significantly reduced SBP, DBP and LVMI after 12 months' treatment compared with HCTZ.Journal of Human Hypertension (2004) 18, 53-59. doi:10.1038/sj.jhh.1001637
- Subjects
ANTIHYPERTENSIVE agents; ANGIOTENSIN II; ECHOCARDIOGRAPHY; HYPERTENSION; THERAPEUTICS; LEFT heart ventricle; HYPERTROPHY
- Publication
Journal of Human Hypertension, 2004, Vol 18, Issue 1, p53
- ISSN
0950-9240
- Publication type
Article
- DOI
10.1038/sj.jhh.1001637